Recent advances in ischemic stroke management
Journal of the Korean Medical Association
; : 775-784, 2016.
Article
em Ko
| WPRIM
| ID: wpr-93736
Biblioteca responsável:
WPRO
ABSTRACT
There have been recent advances in the hyperacute treatment and secondary prevention of ischemic stroke. Thrombolysis with intravenous tissue plasminogen activator has been approved for a 3 to 4.5 hour time window, but the recent controversy over the optimal dose has not been resolved. Five endovascular trials published in 2015 have shown dramatically positive results. Regarding secondary prevention of ischemic stroke, a study suggesting the beneficial effect of a short course of dual antiplatelet therapy has been published. Non-vitamin K antagonist oral anticoagulation agents have been approved for stroke prevention in non-valvular atrial fibrillation. Here, we review these recent advances in ischemic stroke management.
Palavras-chave
Texto completo:
1
Índice:
WPRIM
Assunto principal:
Fibrilação Atrial
/
Inibidores da Agregação Plaquetária
/
Ativador de Plasminogênio Tecidual
/
Acidente Vascular Cerebral
/
Prevenção Secundária
/
Procedimentos Endovasculares
/
Anticoagulantes
Idioma:
Ko
Revista:
Journal of the Korean Medical Association
Ano de publicação:
2016
Tipo de documento:
Article